activity resides. This antiserum had previously been conjugated with fluorescein and thus, whereever it combined with 19S macroglobulin in the section, the combination was made visible on viewing the section by ultraviolet microscopy: in this and in other germinal centres it could be seen that the central cells contained 19S macroglobulin as a cytoplasmic constituent. By using fluoresceinconjugated denatured human y-globulin in a similar way rheumatoid factor itself could be located (Fig 6) , and it appeared in some, though not all of these germinal centres. Similar studies of joint tissues show that rheumatoid factor is produced not only in lymph nodes which are normal sites of antibody production but also in germinal centres and plasma cells in the affected synovial membrane itself.
If we postulate that production of rheumatoid factor is an abnormal immunological response on the part of an individual to the stimulus ofhis own antibody y-globulin altered by combination with antigen, it could be envisaged that such antigenantibody complexes might well involve autoantibodies as well as hetero-antibodies. What, then, is the evidence that rheumatoid arthritis patients produce auto-antibodies in the same way as, for example, patients with systemic lupus erythematosus? Positive LE cell teststhe hallmark of auto-antibody production in SLEare seldom found in rheumatoid arthritis patients, at least in our experience. However, the immunofluorescent test for anti-nuclear auto-antibodies, which gives nearly 100% positive results in SLE, is also positive in a proportion of cases of classical or definite rheumatoid arthritis; according to our investigation of cases at Taplow, about 20 % show this phenomenon (Fig 7) . Apart from systemic lupus, a higher incidence of positive antinuclear factor (ANF) tests has been reported only in Sjogren's syndrome, where rheumatoid factor tests are usually positive also. Some of the other auto-antibodies characteristic of SLE are less often found in rheumatoid arthritis than ANF but, nevertheless, are present significantly more often than in normal individuals.
In summary, therefore, the changes which I have described in the synovial membranes of affected joints and in the lymph nodes are essentially immunological changes and are intimately concerned with the production of rheumatoid factors. Secondly, there are reasonable grounds for thinking that rheumatoid factors are antibodies directed at altered human y-globulinthat is to say they are auto-antibodies of a rather special sort. Thirdly, we know that some rheumatoid patients produce auto-antibodies, such as antinuclear factor, of the type which are characteristic of systemic lupus erythematosus. It therefore seems to be a reasonable working hypothesis Perhaps the best way a pwdiatrician can introduce this subject to an assembly of orthopedic surgeons is to remind them that quite often the beginning of the disorder is without obvious arthritis. Recognition of the disease can be difficult when high fever, a rash, extreme malaise, a polymorphonuclearcytosis, adenopathy, a raised sedimentation rate and possibly pneumonitis and pericarditis are the main clinical features. Arthritis is not long delayed and the diagnosis becomes clearer. Of course this acute onset is not invariable in childhood and insidious joint involvement is the first complaint, as in adults. These are the cases that are often brought to the orthopaedic surgeon.
Diagnosis: Sometimes at first one joint alone is affected and then tuberculosis is suspected or purulent arthritis, in view of the leucocytosis and fever. This usually leads to a joint biopsy, but this can be undertaken too readily, insufficient attention being paid to other evidence, such as a possible negative Mantoux reaction, glandular enlargement and other systemic signs, none of which favours the two infections mentioned. Before long other joints become involved and doubts are resolved. I have seen immobility and increased stiffness of a joint follow biopsy, though this is not the rule.
Treatment: Rest at first, followed by physiotherapy and graded activity form the basis of treatment. Spontaneous remission may occur but this is not always maintained and after some months' freedom from symptoms there may be a relapse. In that event steroid therapy should be considered. Most poediatricians are agreed that steroids are indicated when there is profound systemic involvement and in fulminating cases with fever and severe polyarthritis. Doubt has been raised on the advisability of using this form of treatment under other circumstances. Those who take this view are mainly physicians who have had disappointing results in adults. After many years' experience in children with this complaint I am convinced of the value of steroid treatment when simple measures have failed.
To obtain the best results certain principles should be followed. Initial dosage should be high enough to bring systemic symptoms under control and to reduce arthritis to the mniumum. Lowering of the sedimentation rate is a good indication of the effectiveness of treatment, but a normal figure is not always reached immediately. Thereafter dosage should gradually be reduced to a maintenance level, below which symptoms recur or a sharp rise in the sedimentation rate takes place. Dosage of steroid and duration of treatment cannot be strictly laid down, as cases differ in their response depending on the severity of the disease.
By combining prednisolone with ACTH the disease is generally brought under control and maintained so on a reasonably low total dosage with less likelihood of cortical adrenal atrophy (for a scheme of dosage see Table 1 ). The best results can be expected if steroid therapy is begun during the first six months of the disease. The duration of treatment required cannot be foretold, but eighteen months is adequate in the majority. In some children more than one course is necessary to deal with recurrences several months or years after steroid therapy is stopped. After five years in remission relapses are unusual.
With steroid treatment there is usually some improvement within a week. Fever quickly subsides, lymph glands and the spleen, if enlarged, diminish in size, and decrease in joint pain and stiffness leads to greater mobility. By modifying the degree of arthritis, serious permanent damage is generally prevented and in a hundred cases which we followed at Great Ormond Street and University College Hospital, 85 % had no joint involvement or only slight residual damage an appreciable time after the steroid treatment had been completed. Naturally there will always be some children in whom a remission is difficult to establish and steroids may have to be continued for a number of years; even then the ultimate prognosis in regard to the state of the joints may not be so favourable when at length the disease burns itself out and steroid therapy can be safely withheld. Nevertheless it is rare these days with this mode of therapy for our patients to be left with the extreme degrees of ankylosis which occurred in the past.
Intra-articular injections of hydrocortisone (or 6-methyl prednisolone or prednisolone trimethyl acetate) can also be given alone or in conjunction with oral prednisolone. They are particularly useful in persistent large effusions in the kneejoints. There is usually a prompt response, but fluid may reaccumulate and injections may have to be repeated several times. Toxic effects of steroids: Children receiving high dosage or prolonged steroid therapy should be given potassium chloride and calcium lactate, 1-2 g of each daily to counteract electrolytic disturbances, and oral penicillin (phenoxymethyl penicillin, 125 mg b.d.) as a protection against masked infection.
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A high protein and limited carbohydrate diet is also desirable in view of the protein loss produced by steroids. Even with these precautions osteoporosis, most noticeable in the vertebral column, may develop and routine X-ray examination of the spine every few months is desirable to detect early signs of vertebral collapse. Children who already suffer from generalized skeletal decalcification, due to enforced immobilization before steroid therapy, are specially prone to this complication in a comparatively short period after treatment is begun. When vertebre begin to be affected the child should be kept ambulant to prevent further decalcification resulting from bed rest, and the dose of steroids should be reduced appreciably or stopped altogether, short of provoking a serious relapse. Though obviously an alarming discovery, this is not serious; no neurological complications occur and the condition is reversible if the steps just mentioned are taken. The scheme of combined steroid therapy which has been outlined, enabling a lower satisfactory total dosage to be used, may also help to lower the incidence of this complication.
The only other side-effect of any significance is on growth, but this begins again if treatment can be halted before the onset of puberty, as it has no effect on epiphyseal development. Anabolic drugs have no compensating effect and human growth hormone, which should prove valuable in this respect, is not generally available. Other complications which are seen in adults are hazards which do not often occur in children. The risk, therefore, seems justifiable in all but mild forms of the disease, in view of the danger of death or severe crippling if rheumatoid arthritis is left uncontrolled. Since the pituitary-adrenal response may have become poor with prolonged steroid therapy, even though it has ceased for a few months, infections and surgical procedures should always be covered by an increased dose.
Orthopaedic measures: Surgery is rarely indicated during the active stage of the disease and should be postponed until this has ceased. Then in certain cases operations may have to be considered to correct serious joint deformities or a severe unilateral shortened lower limb. During the acute stage traction may be required to overcome flexion of one of the larger joints such as the knee or hip, which may arise quite suddenly with muscular spasm. A series of corrective walking plasters may also serve, but prolonged immobility of an arthritic joint in a fixed plaster is not desirable. The days are past when rheumatoid arthritis was treated by a lengthy period in bed. As soon as the child can manage to get about without much pain he should be encouraged to do so, even though slight pyrexia and some joint inflammation persist. Steroid therapy will enable this principle to be carried out much more easily.
Constant co-operation between the orthopedic surgeon and the pediatrician is in the best interests of the child with rheumatoid arthritis and is likely to have the most favourable results.
Mr John Bastow (Royal United Hospital, Bath)
The Place of Surgery in Rheumatoid Arthritis
The past decade has shown a widespread revival of interest in surgery in rheumatoid disease. The symposium on rheumatoid arthritis, attended by physicians and orthopaedic surgeons under the auspices of the Empire Rheumatism Council in March 1961, gave evidence of the growing need for closer co-operation between the rheumatologist and the orthopedic surgeon in the management of this disease.
The associations of hand surgeons, on a worldwide scale, have produced a flood of papers dealing with the rheumatoid hand during the past few years (Fowler 1955 , Harris & Riordan 1954 . In Heinola in Finland, collaboration between rheumatologist and surgeon has been active since 1952; and the Karolinska Institute in Stockholm, as Dr Berglund told us when he attended our symposium in 1961, also has done much work in this field.
In the past in this country, surgery in this disease has been largely confined to salvage operations, undertaken when the disease has burnt itself out or is at least in remission. The facts that surgery is no cure for rheumatoid arthritis, that many rheumatoid hands function quite well in spite of gross deformity, the enormous multiplicity of the joints involved, that remissions often occur naturally and, lately, the widespread use of steroids in treating rheumatoid arthritis, have all discouraged surgical intervention while the disease is still alive. However, an increased knowledge of the pathology, particularly the recognition of the almost malignant role of the rheumatoid synovial tissue in joint and tendon sheaths that reaches a stage when it invades bone, articular cartilage, supporting ligaments and tendons, destroying all before it, renders early surgery both logical and necessary. Irreversible changes occur. Once pannus has invaded the articular surface, the cartilage does not regenerate; once a joint has become unstable from ligamentous and bone
